1007-3418
2009 Issue 6
..............page:401-402
The preliminary study of metallic stent implantation in combination with three-dimensional conformal radiation therapy in the treatment of hepatocellular carcinoma patients with portal vein tumor thrombus
WANG Cheng-gang;WANG Xiao-lin;GONG Gao-quan;CHEN Gang;ZENG Zhao-chong;QIU Wei-li;LIN Gen-lai;CHEN Yi;LI Guo-ping
WANG Cheng-gang;WANG Xiao-lin;GONG Gao-quan;CHEN Gang;ZENG Zhao-chong;QIU Wei-li;LIN Gen-lai;CHEN Yi;LI Guo-ping
..............page:417-421
Effects of sirolimus on the growth of transplanted hepatocellular carcinoma
ZHANG Jian;LI Hua;WANG Gen-shu;JIANG Nan;YANG Yang;CHEN Gui-hua
ZHANG Jian;LI Hua;WANG Gen-shu;JIANG Nan;YANG Yang;CHEN Gui-hua
..............page:413-416
Surgical treatment for hepatocellular carcinoma
Group of Liver, Chinese Society of Surgery, Chines
Group of Liver, Chinese Society of Surgery, Chines
..............page:411-412
Expert consensus on standardization of the management of primary liver cancer
Chinese Societies of Liver Cancer;Clinical Oncology, Chinese Anti-Cancer Association;Liver Cancer Study Group, Chinese Society of Hepat
Chinese Societies of Liver Cancer;Clinical Oncology, Chinese Anti-Cancer Association;Liver Cancer Study Group, Chinese Society of Hepat
..............page:403-410
Chinese herbal medicine induced liver injury
GAO Xu-dong;FAN Yan-hua
GAO Xu-dong;FAN Yan-hua
..............page:478-480
Current advances in molecular targeted therapy of primary hepatocellular carcinoma
YU Lei;DAI Zhi;ZHOU Jian;FAN Jia
YU Lei;DAI Zhi;ZHOU Jian;FAN Jia
..............page:475-477
The clinical survey of anxiety and depression for rural chronic hepatitis B patients
LI Yu-long;ZHOU Jian-fang
LI Yu-long;ZHOU Jian-fang
..............page:474
A reduction study of seroeonversion of HBsAg in chronic hepatitis B patients with HBeAg positive by combination treatment with interferon and lamivudine
YU Shu-li;QIN Lan-ying;WANG Can;YU Li-jun;GUO Chao-ying;WANG Yao-zong
YU Shu-li;QIN Lan-ying;WANG Can;YU Li-jun;GUO Chao-ying;WANG Yao-zong
..............page:472-473
Etiologies of liver cirrhosis and their relationships with glucose metabolism disorders in Shanghai
XU Zheng-fie;ZHONG Yan;FAN Jian-gao
XU Zheng-fie;ZHONG Yan;FAN Jian-gao
..............page:470-471
Investigating the relationship between anti-gp210 antibody and clinical basic profile of primary billiary cirrhosis
YANG Jin-hui;YOU Li-ying;XU Zhi-yuan;YANG Li-hong
YANG Jin-hui;YOU Li-ying;XU Zhi-yuan;YANG Li-hong
..............page:468-469
Construction, expression and characterization of humanized single-chain Fv dimers for hepatoceilular carcinoma
BIE Cai-qun;YANG Dong-hua;LIU Liu
BIE Cai-qun;YANG Dong-hua;LIU Liu
..............page:466-467
The protective effect and mechanism of anti-lGFBPrP1 antibody for hepatic fibrosis induced thioacetamide
LIU Li-xin;ZHANG Qian-qian;ZHANG Hai-yan
LIU Li-xin;ZHANG Qian-qian;ZHANG Hai-yan
..............page:464-465
The cardiac abnormalities in liver cirrhotic patients with portal hypertension
LI Lei;PING Chun-xia;ZHANG Bin;DONG Pei-ling;YAN Hai-yan;DING Hui-guo
LI Lei;PING Chun-xia;ZHANG Bin;DONG Pei-ling;YAN Hai-yan;DING Hui-guo
..............page:462-463
Retrospective analysis of maternal and infant birth features of hepatoblastoma patients
PU Cong-lun;GUO Chun-bao;JIN Xian-qing;DENG Chun;ZHANG Ming-man;LI Ying-cun;KANG Quan
PU Cong-lun;GUO Chun-bao;JIN Xian-qing;DENG Chun;ZHANG Ming-man;LI Ying-cun;KANG Quan
..............page:459-461
Establishment of PEGI0 transgenic mouse and effects of PEG10 on growth, metastasis of transplanted tumor in mice
LIU Yao;LIN Jus-heng;ZHENG Xin-min;TAN Jin-quan;WANG Zhi-jun;ZHANG Qiang;WU Wei;CHANG Ying
LIU Yao;LIN Jus-heng;ZHENG Xin-min;TAN Jin-quan;WANG Zhi-jun;ZHANG Qiang;WU Wei;CHANG Ying
..............page:455-458
Effect of danshensu on activation of JNK pathway in hepatic stellate cells(HSCs) induced by IL-1 beta
YU Bin-bin;DAI Li-li;LI Xin;LI Dong;JIANG Zhong-hua
YU Bin-bin;DAI Li-li;LI Xin;LI Dong;JIANG Zhong-hua
..............page:451-454
Effects of transforming growth factor beta 3 on the histopathology and expression of collagen I in experimental hepatic fibrotic rats
LIU Ping;GAG Xiao-liang;YU Jiao;QIAN Wei;XU Ke-shu
LIU Ping;GAG Xiao-liang;YU Jiao;QIAN Wei;XU Ke-shu
..............page:446-450
Pathogenesis of liver fibrosis in patients with chronic hepatitis B
SHI Jun;HAO Jing-hua;REN Wan-hua;ZHU Ju-ren;WANG Shu-yun;XIE Ying-bo
SHI Jun;HAO Jing-hua;REN Wan-hua;ZHU Ju-ren;WANG Shu-yun;XIE Ying-bo
..............page:443-445
Evaluation of Chai Shao Liu Jun Tang for the treatment of chronic hepatitis B
CHI Xiao-ling;WU Li-ming;JIANG Jun-min;CHEN Pei-qiong;TIAN Guang-jun;XIAO Huan-ming;CAI Gao-shu;CHEN Ying;QIAN Ying
CHI Xiao-ling;WU Li-ming;JIANG Jun-min;CHEN Pei-qiong;TIAN Guang-jun;XIAO Huan-ming;CAI Gao-shu;CHEN Ying;QIAN Ying
..............page:440-442
Viral factors influencing histological changes of HBeAg-negative chronic hepatitis B patients with persistently normal serum ALT levels
YANG Yan-hua;XIE Qing;WANG Hui;ZHOU Hui-juan;GUI Hong-lian;CAI Wei;GUO Si-min;YU Hong;GUO Qing
YANG Yan-hua;XIE Qing;WANG Hui;ZHOU Hui-juan;GUI Hong-lian;CAI Wei;GUO Si-min;YU Hong;GUO Qing
..............page:434-439
Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients
FAN Ling-yan;ZHOU Zhi;ZHONG Shan;LING Ning;WANG Zhi-yi;SHI Xiao-feng;ZHANG Da-zhi;REN Hong
FAN Ling-yan;ZHOU Zhi;ZHONG Shan;LING Ning;WANG Zhi-yi;SHI Xiao-feng;ZHANG Da-zhi;REN Hong
..............page:429-433
Comparison of prognosis of small hepatocellular carcinoma patients with hepatitis B virus infection versus hepatitis C virus infection
LI Hui-kai;QIN Yu;LI Xiao-mian;LI Qiang
LI Hui-kai;QIN Yu;LI Xiao-mian;LI Qiang
..............page:426-428
Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines
LIN Fan;LI Yu-yuan;XIA Jin-tang;WEN Min-jie;LAI Yue-yuan;CAI Wen-song;WU Zhao-feng;FAN Shao-feng
LIN Fan;LI Yu-yuan;XIA Jin-tang;WEN Min-jie;LAI Yue-yuan;CAI Wen-song;WU Zhao-feng;FAN Shao-feng
..............page:422-425